Mushroom intoxications presented to emergency departments in South Korea: a 2011‐2019 national registry study

This study aimed to investigate the association of characteristics and clinical outcomes of patients who presented with mushroom intoxication. We conducted a retrospective study of mushroom intoxication cases using national registry data (representative of the period 01 January 2011 to 31 December 2019). Specifically, we analyzed the demographics, vital signs, mental status, intoxication related factors, and clinical presentations of the patients. The outcomes were assessed based on general ward admission, intensive care unit (ICU) admission, length of hospitalization, and mortality. The t-test or chi-square test were used to compare the emergency department (ED) discharge group and admission group. Logistic regressions were used to predict patients that were high-risk with regards to being admitted. A total of 393 patients with mushroom intoxication were presented at the ED, and the highest number of visits occurred in the month of September. Overall, 277 (70.5%) patients were discharged from the ED and 116 (29.5%) patients were admitted. Of these, 25 (6.4%) patients were admitted to the ICU, and 3 (2.6%) patients died. Patients are more likely to be admitted to the general ward or ICU when symptoms presented after 6 h: 6 to 24 h (Odds ratio (OR) 2.158; 95% Confidence interval (CI), 1.218–3.816) or >24 h (OR: 3.382; 95% CI, 1.438–8.050). Additionally, when the patients presented with diarrhea, they were more likely to be discharged with favorable outcomes with a less likelihood for admission (OR: 0.237; 95% CI, 0.093–0.523). Most cases of mushroom intoxication presented with gastrointestinal symptoms and followed a benign course. The longer time to onset of symptoms increased the likelihood of hospitalization. Clinicians should evaluate more carefully, observe, or admit those with delayed symptom onset.

Mushroom poisoning; Emergency department; South Korea; Podostroma; Registry

[1] Sohn CH. Type and treatment of toxic mushroom poisoning in Korea. Journal of the Korean Medical Association. 2015; 58: 818–824.

[2] Lurie Y, Lewinsohn D, Kurnik D. An outbreak of mushroom poisoning in Israel during the 2020 fall and winter season: an unexpected outcome of COVID-19 restrictions? Clinical Toxicology. 2022; 60: 386–388.

[3] Seok SJ, Kim YS, Kim WG, Suh JS, Jeong MH, Lim KS, et al. Encyclopedia of Poisonous Mushrooms. Blue Happiness Press: Seoul. 2011.

[4] Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Critical Care Medicine. 2005; 32: 427–436.

[5] Erden A, Esmeray K, Karagöz H, Karahan S, Gümüşçü HH, Başak M, et al. Acute liver failure caused by mushroom poisoning: a case report and review of the literature. International Medical Case Reports Journal. 2013; 6: 85–90.

[6] Ward J, Kapadia K, Brush E, Salhanick SD. Amatoxin poisoning: case reports and review of current therapies. The Journal of Emergency Medicine. 2013; 44: 116–121.

[7] Korea Forest Research Institute. National Academy of Agricultural Science. Poisonous mushroom in the woods. Korea Forest Research Institute: Seoul. 2014.

[8] Kim T, Lee D, Lee JH, Lee Y, Oh BJ, Lim KS, et al. Predictors of poor outcomes in patients with wild mushroom-induced acute liver injury. World Journal of Gastroenterology. 2017; 23: 1262–1267.

[9] Wennig R, Eyer F, Schaper A, Zilker T, Andresen-Streichert H. Mushroom poisoning. Deutsches Ärzteblatt International. 2020; 117: 701–708.

[10] Broussard CN, Aggarwal A, Lacey SR, Post AB, Gramlich T, Henderson JM, et al. Mushroom poisoning—from diarrhea to liver transplantation. The American Journal of Gastroenterology. 2001; 96: 3195–3198.

[11] Ahn BM, Lee DS, Lee KM, Kang SB, Yang JM, Park YM, et al. Amatoxins poisonings in Korea. The Korean Journal of Hepatology. 2000; 6: 340–349.

[12] Schenk-Jaeger KM, Rauber-Lüthy C, Bodmer M, Kupferschmidt H, Kullak-Ublick GA, Ceschi A. Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity. European Journal of Internal Medicine. 2012; 23: e85–e91.

[13] Yun KS, Cho JS, Lim YS, Jang JH, Yang HJ, Choi WS. Effect of alcohol intake on the severity of injuries caused by slipping down. Clinical and Experimental Emergency Medicine. 2020; 7: 170–175.

[14] Jung KY, Kim T, Hwang SY, Lee TR, Yoon H, Shin TG, et al. Deliberate self-harm among young people begins to increase at the very early age: a nationwide study. Journal of Korean Medical Science. 2018; 33: e191.

[15] Mühlberg W, Becher K, Heppner HJ, Wicklein S, Sieber C. Acute poisoning in old and very old patients: a longitudinal retrospective study of 5883 patients in a toxicological intensive care unit. Zeitschrift FüR Gerontologie Und Geriatrie. 2005; 38: 182–189.

[16] Lee WJ, Choi SM, Kyong YY, Kim HM, Youn CS, Jeong SK, et al. Clinical analysis of acute poisoning in elderly patients. Journal of the Korean Geriatrics Society. 2009; 13: 24–30.

[17] Saikawa Y, Okamoto H, Inui T, Makabe M, Okuno T, Suda T, et al. Toxic principles of a poisonous mushroom Podostroma cornu-damae. Tetrahedron. 2001; 57: 8277–8281.

[18] Kim HN, Do HH, Seo JS, Kim HY. Two cases of incidental Po-dostroma cornudamae poisoning. Clinical and Experimental Emergency Medicine. 2016; 3: 186–189.

[19] Ahn JY, Seok SJ, Song JE, Choi JH, Han SH, Choi JY, et al. Two cases of mushroom poisoning by Podostroma cornu-damae. Yonsei Medical Journal. 2013; 54: 265–268.

[20] Jang J, Kim CH, Yoo JJ, Kim MK, Lee JE, Lim AL, et al. An elderly man with fatal respiratory failure after eating a poisonous mushroom Podostroma cornu-damae. Tuberculosis and Respiratory Diseases. 2013; 75: 264–268.

[21] Yang JN, Kang JH, Kang YS, Seok SJ, Kim WK. A case of Podostroma cornu-damae intoxication similar to drug hypersensitivity syndrome. Korean Journal of Medical Education. 2013; 85: 223–228.

[22] Quoc QL, Bich TCT, Jang JH, Park HS. Recent update on the management of anaphylaxis. Clinical and Experimental Emergency Medicine. 2021; 8: 160–172.

[23] Scheid HV, Viégas Sallis ES, Riet-Correa F, Schild AL. Ramaria flavo-brunnescens mushroom poisoning in South America: a comprehensive review. Toxicon. 2022; 205: 91–98.

[24] Elkhateeb W, Elnahas M, Wenhua L, Galappaththi MCA, Daba GM. The coral mushrooms Ramaria and Clavaria. Studies in Fungi. 2021; 6: 495–506.

[25] Ahishali E, Boynuegri B, Ozpolat E, Surmeli H, Dolapcioglu C, Dabak R, et al. Approach to mushroom intoxication and treatment: can we decrease mortality? Clinics and Research in Hepatology and Gastroenterology. 2012; 36: 139–145.

[26] Kaufmann P. Mushroom poisonings: syndromic diagnosis and treatment. Wiener Medizinische Wochenschrift. 2007; 157: 493–502. (In German)

[27] Eren SH, Demirel Y, Ugurlu S, Korkmaz I, Aktas C, Güven FMK. Mushroom poisoning: retrospective analysis of 294 cases. Clinics. 2010; 65: 491–496.

[28] Diaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Critical Care Medicine. 2005; 33: 419–426.

[29] Mărginean CO, Meliţ LE, Mărginean MO. Mushroom intoxication, a fatal condition in Romanian children: two case reports. Medicine. 2019; 98: e17574.

[30] Kim SY, Baek YH, Han SY, Lee SW, Roh YH, Kim KW, et al. Mushroom poisoning by Macrolepiota neomastoidea. The Korean Journal of Gastroenterology. 2018; 71: 94–97.

[31] Vanooteghem S, Arts J, Decock S, Pieraerts P, Meersseman W, Verslype C, et al. Four patients with amanita Phalloides poisoning. Acta Gastro-Enterologica Belgica. 2014; 77: 353–356.